Not Tagged
Not Tagged
[]
a full house for at #ash2022 presenting the exciting results of optimum/muk9. early screening for ultra high risk myeloma is feasible within the nhs, and good outcomes can be achieved with intensive and extended treatment. involved in trial design. 
Consultant Haematologist. Interested in haemato-oncology in general and multiple myeloma in particular.